20 articles
A 600,000-person study finds semaglutide and other GLP-1 drugs reduce substance use disorders by up to 25% and lower overdose deaths.
Stanford researchers found genetic variants in ~10% of people that blunt GLP-1 drug effectiveness, pointing toward precision diabetes care.
A novel β2 agonist pill boosts fat burning via skeletal muscle, preserving muscle mass while improving blood sugar in early trials.
New research reveals genetic 'GLP-1 resistance' affects 1 in 10 people, explaining why popular diabetes and weight-loss drugs fail for some patients.
Experts say the next era of obesity care pairs GLP-1 medications with precision medicine, endoscopic procedures, and surgery for lasting results.
New research reveals GLP-1 drugs like Ozempic deliver stronger results for 'see-food' eaters than those who eat due to stress or emotions.
A UC San Diego trial shows ION224 blocks liver fat production, cutting inflammation and scarring in 60% of MASH patients.
New research reveals fructose and glucose trigger completely different hunger signals in the brain, even though they have the same calories.
A new rat study finds fish oil calms inflammation and improves blood sugar control in non-obese type 2 diabetes — a largely overlooked patient group.
New mouse research shows zero-sucrose diets worsened blood sugar, gut bacteria, and liver health — even on a low-fat diet.
New research shows purple potatoes cause smaller insulin spikes and reduce inflammation markers compared to white and yellow varieties.
Chilling cooked potatoes transforms starch into resistant form, dramatically lowering glycemic impact compared to hot potatoes.
Adding broccoli, vinegar, or lemon juice to potatoes dramatically reduces blood sugar spikes and insulin demand in new research.
A major 6-year European trial found a calorie-reduced Mediterranean diet plus exercise slashed type 2 diabetes risk by nearly a third.
New research reveals fructose acts as a metabolic signal promoting fat storage, insulin resistance, and chronic disease risk.
Large-scale studies reveal concerning diabetes risk from potato consumption, even when prepared without frying or high-fat toppings.
New AI-discovered peptide mimics Ozempic's weight loss effects but targets only the brain's appetite center, avoiding nausea and muscle loss.
A protein thought only to burn fat secretly protects fat cell health from inside the nucleus, reshaping obesity and metabolic disease research.
A 40-year study of 205,000 people reveals french fries drive diabetes risk, but baked or boiled potatoes are largely in the clear.
New research reveals how hormone FGF21 activates brain circuits to boost metabolism and reverse obesity, offering alternative to GLP-1 drugs.
